Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. 1948242-59-8
2. A4v35p6kws
3. (3r)-3-[3-amino-4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]-3-cyclopentylpropanenitrile
4. (3r)-3-(3-amino-4-(7h-pyrrolo(2,3-d)pyrimidin-4-yl)pyrazol-1-yl)-3-cyclopentylpropanenitrile
5. Refchem:1098160
6. Rovadicitinib [inn]
7. Chembl5314485
8. Schembl17858699
9. Gtpl12384
10. Us10561657, Example 5
11. Bdbm433327
12. Glxc-27915
13. Example 5 [us10561657b2]
14. Da-77542
15. Hy-148798
16. Cs-0641156
17. (3r)-3-[3-amino-4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h- Pyrazol-1-yl]-3-cyclopentylpropanenitrile
18. (betar)-3-amino-beta-cyclopentyl-4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazole-1-propanenitrile
19. 1h-pyrazole-1-propanenitrile, 3-amino-beta-cyclopentyl-4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-, (betar)-
| Molecular Weight | 321.4 g/mol |
|---|---|
| Molecular Formula | C17H19N7 |
| XLogP3 | 1.8 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 109 |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 483 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE